{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:10:25Z","timestamp":1794345025505,"version":"4.9.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":373,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jacc.2024.03.380","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T08:35:11Z","timestamp":1712565311000},"page":"137-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Randomized Trial of a Selective Aldose\u00a0Reductase Inhibitor in Patients With Diabetic\u00a0Cardiomyopathy"],"prefix":"10.1016","volume":"84","author":[{"suffix":"Jr.","given":"James L.","family":"Januzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Del Prato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2724-4086","authenticated-orcid":false,"given":"Justin A.","family":"Ezekowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrien E.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.P.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Marwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Perfetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Rosenstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8335-735X","authenticated-orcid":false,"given":"W.H. Wilson","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7456-1570","authenticated-orcid":false,"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jacc.2024.03.380_bib1","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.2337\/dci22-0014","article-title":"Heart failure: an underappreciated complication of diabetes. A consensus report of the American Diabetes Association","volume":"45","author":"Pop-Busui","year":"2022","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.jacc.2024.03.380_bib2","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1007\/s00125-012-2579-0","article-title":"High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes","volume":"55","author":"Boonman-de Winter","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacc.2024.03.380_bib3","author":"Bozkurt","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacc.2024.03.380_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/743503","article-title":"Evidence for a specific diabetic cardiomyopathy: an observational retrospective echocardiographic study in 656 asymptomatic type 2 diabetic patients","volume":"2015","author":"Pham","year":"2015","journal-title":"Int J Endocrinol"},{"issue":"2 suppl","key":"10.1016\/j.jacc.2024.03.380_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/2047487319878371","article-title":"Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications","volume":"26","author":"Dal Canto","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2024.03.380_bib6","article-title":"Complications of diabetes 2017","volume":"2018","author":"Papatheodorou","year":"2018","journal-title":"J\u00a0Diabetes Res"},{"issue":"9","key":"10.1016\/j.jacc.2024.03.380_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101156","article-title":"The pathophysiological basis of diabetic cardiomyopathy development","volume":"47","author":"Avagimyan","year":"2022","journal-title":"Curr Probl Cardiol"},{"issue":"1","key":"10.1016\/j.jacc.2024.03.380_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12933-023-01811-w","article-title":"Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation","volume":"22","author":"Gopal","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacc.2024.03.380_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ahj.2022.11.003","article-title":"Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart\u00a0Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy","volume":"256","author":"Januzzi","year":"2023","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.jacc.2024.03.380_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12933-024-02135-z","article-title":"Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial","volume":"23","author":"Januzzi","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"10.1016\/j.jacc.2024.03.380_bib11","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.jacc.2024.03.380_bib12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10741-012-9313-3","article-title":"Diabetic cardiomyopathy: pathophysiology and clinical features","volume":"18","author":"Miki","year":"2013","journal-title":"Heart Fail Rev"},{"issue":"6","key":"10.1016\/j.jacc.2024.03.380_bib13","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.jacc.2024.03.380_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/ars.2009.2502","article-title":"Early neural and vascular dysfunctions in diabetic rats are largely sequelae of increased sorbitol oxidation","volume":"12","author":"Ido","year":"2010","journal-title":"Antioxid Redox Signal"},{"issue":"9","key":"10.1016\/j.jacc.2024.03.380_bib15","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1161\/CIRCRESAHA.109.213447","article-title":"Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model","volume":"106","author":"Ramasamy","year":"2010","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.jacc.2024.03.380_bib16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2174\/1389557515666150909143737","article-title":"Updates on aldose reductase inhibitors for management of diabetic complications and non-diabetic diseases","volume":"16","author":"Grewal","year":"2016","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.jacc.2024.03.380_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.636267","article-title":"Aldose reductase: an emerging target for development of interventions for diabetic cardiovascular complications","volume":"12","author":"Jannapureddy","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.jacc.2024.03.380_bib18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.2337\/diacare.27.2.448","article-title":"Cardiac abnormalities in diabetic patients with neuropathy: effects of aldose reductase inhibitor administration","volume":"27","author":"Johnson","year":"2004","journal-title":"Diabetes Care"},{"issue":"16","key":"10.1016\/j.jacc.2024.03.380_bib19","doi-asserted-by":"crossref","first-page":"e894","DOI":"10.1161\/CIR.0000000000000483","article-title":"Prioritizing functional capacity as a principal end point for therapies oriented to older adults with cardiovascular disease: a scientific statement for healthcare professionals from the American Heart Association","volume":"135","author":"Forman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.03.380_bib20","article-title":"The effect of SGLT-2 inhibitors on cardiorespiratory fitness capacity: a systematic review and meta-analysis","volume":"13","author":"Peng","year":"2022","journal-title":"Front Physiol"},{"issue":"9","key":"10.1016\/j.jacc.2024.03.380_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2022.119300","article-title":"GLP-1 regulates exercise endurance and skeletal muscle remodeling via GLP-1R\/AMPK pathway","volume":"1869","author":"Wu","year":"2022","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"5","key":"10.1016\/j.jacc.2024.03.380_bib22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/CIRCOUTCOMES.115.001958","article-title":"Development and validation of a short version of the Kansas City Cardiomyopathy Questionnaire","volume":"8","author":"Spertus","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"2","key":"10.1016\/j.jacc.2024.03.380_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0895-4356(93)90053-4","article-title":"The Physical Activity Scale for the Elderly (PASE): development and evaluation","volume":"46","author":"Washburn","year":"1993","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"12","key":"10.1016\/j.jacc.2024.03.380_bib24","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.jacc.2024.03.380_bib25","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.jacc.2024.03.380_bib26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1096\/fj.01-0368fje","article-title":"Aldose reductase activation is a key component of myocardial response to ischemia","volume":"16","author":"Hwang","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.jacc.2024.03.380_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fphar.2012.00087","article-title":"Aldose reductase, oxidative stress, and diabetic mellitus","volume":"3","author":"Tang","year":"2012","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacc.2024.03.380_bib28","doi-asserted-by":"crossref","first-page":"7073","DOI":"10.12659\/MSM.917011","article-title":"Polymorphisms in sorbitol-aldose reductase (polyol) pathway genes and their influence on\u00a0risk of diabetic retinopathy among Han\u00a0Chinese","volume":"25","author":"Li","year":"2019","journal-title":"Med Sci Monit"},{"issue":"3","key":"10.1016\/j.jacc.2024.03.380_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/13543776.2019.1582646","article-title":"Aldose reductase inhibitors: 2013-present","volume":"29","author":"Quattrini","year":"2019","journal-title":"Expert Opin Ther Pat"},{"issue":"3","key":"10.1016\/j.jacc.2024.03.380_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jacc.2014.10.044","article-title":"Exercise limitation associated with asymptomatic left ventricular impairment: analogy with stage B heart failure","volume":"65","author":"Kosmala","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724066130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724066130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T09:52:13Z","timestamp":1752573133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109724066130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0735109724066130"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2024.03.380","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized Trial of a Selective Aldose\u00a0Reductase Inhibitor in Patients With Diabetic\u00a0Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2024.03.380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}